To Investigate the Clinical Effect of Acupuncturing Ba Liao for Neurogenic Bladder Under the Guidance of Ultrasound
Conditions
Brief summary
To explore acupuncture under the premise of real-time, dynamic and accurate positioning of Ba liao point with ultrasound, observe the clinical efficacy of treating neurogenic bladder, clarify the essence of acupoints, and provide a new method for the standardization of acupuncture and moxibustion.
Interventions
OTHERAcupuncturing Ba Liao point under ultrasound guidance
Acupuncturing Ba Liao point under ultrasound guidance
Sponsors
Qilu Hospital of Shandong University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Healthy volunteers
No
Inclusion criteria
1. The diagnosis of neurogenic bladder conforms to the main points; 2. Symptoms and signs: patients with lower urinary tract dysfunction such as frequency of urination, urgency of urination, inadequacy of urine or retention of urine, urinary incontinence; Physical examination showed paresthesia in perineum and saddle area. 3. Auxiliary examination; Routine urine examination, B - ultrasonography of urinary system and urodynamic examination. 4. Indwelling catheter has been removed; 5. Conscious and able to accurately express symptoms and signs; 6. Patients who inform patients and their families of the research situation in detail and obtain their consent for treatment. \-
Exclusion criteria
1. Lower urinary tract dysfunction caused by non-nervous system factors such as urethral calculi and organic obstruction; 2. patients with serious heart and lung diseases, liver and hematopoietic diseases and mental diseases; 3. patients with prostate cancer, urethral stricture, bladder neck fibrosis, interstitial cystitis, glandular cystitis and other diseases; 4. patients implanted with urethral stents or sacral nerve electrodes; 5. pregnant and lactation women; 6. Fear of acupuncture, needle-sickness and blood sickness. -
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Urodynamic study | Once every two weeks:Before treatment, two weeks after treatment, four weeks after treatment | Residual urine volume, maximum urine flow rate, average urine flow rate, urination time, urine flow time and urine flow rate were assessed |
| Neurogenic bladder symptom score | Once every two weeks:Before treatment, two weeks after treatment, four weeks after treatment.followed up for 3 months after treatment | Patients were evaluated for neurogenic bladder symptoms |
Countries
China
Contacts
Primary ContactYijun Du, Master
Outcome results
None listed